Company intelligence / Profile preview
Nemysis Ltd
Dublin, County Dublin, Irelandnemysisltd.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The nanoparticulate iron product demonstrated correction of human iron deficiency anemia without negatively impacting the gut microbiome in controlled repeat-dose clinical trials. The E40 enzyme effectively destroys immunogenic gluten epitopes resistant to gastric enzymes, reducing inflammatory responses in gluten-sensitive individuals[4][5].
- Therapeutic areas
- GastroenterologyHematology
- Modalities
- Nanoparticulate food supplements/nutritional supplementsEnzymatic therapy (endopeptidase)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Nemysis Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nemysis Ltd.